These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Glycocalyx Damage Within Human Liver Grafts Correlates With Graft Injury and Postoperative Graft Function After Orthotopic Liver Transplantation. Schiefer J; Faybik P; Koch S; Tudor B; Kollmann D; Kuessel L; Krenn CG; Berlakovich G; Baron DM; Baron-Stefaniak J Transplantation; 2020 Jan; 104(1):72-78. PubMed ID: 31283668 [TBL] [Abstract][Full Text] [Related]
3. The Role of Macrophage Migration Inhibitory Factor in Remote Ischemic Conditioning Induced Hepatoprotection in a Rodent Model of Liver Transplantation. Emontzpohl C; Stoppe C; Theißen A; Beckers C; Neumann UP; Lurje G; Ju C; Bernhagen J; Tolba RH; Czigany Z Shock; 2019 Nov; 52(5):e124-e134. PubMed ID: 30601408 [TBL] [Abstract][Full Text] [Related]
4. Release of danger signals during ischemic storage of the liver: a potential marker of organ damage? Liu A; Jin H; Dirsch O; Deng M; Huang H; Bröcker-Preuss M; Dahmen U Mediators Inflamm; 2010; 2010():436145. PubMed ID: 21197406 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of Early Allograft Function Using the Liver Graft Assessment Following Transplantation Risk Score Model. Agopian VG; Harlander-Locke MP; Markovic D; Dumronggittigule W; Xia V; Kaldas FM; Zarrinpar A; Yersiz H; Farmer DG; Hiatt JR; Busuttil RW JAMA Surg; 2018 May; 153(5):436-444. PubMed ID: 29261831 [TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor as a potential predictor for requirement of renal replacement therapy after orthotopic liver transplantation. Stefaniak J; Schiefer J; Miller EJ; Krenn CG; Baron DM; Faybik P Liver Transpl; 2015 May; 21(5):662-9. PubMed ID: 25762421 [TBL] [Abstract][Full Text] [Related]
7. Early release of macrophage migration inhibitory factor after liver ischemia and reperfusion injury in rats. Liu A; Fang H; Dirsch O; Jin H; Dahmen U Cytokine; 2012 Jan; 57(1):150-7. PubMed ID: 22136975 [TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokine MIF plays a role in the pathogenesis of type-2 diabetes mellitus, but does not affect hepatic mitochondrial function. Rodriguez-Sosa M; Cabellos-Avelar T; Sanchez-Zamora Y; Juárez-Avelar I; García-Reyes E; Lira-León A; Benítez-Flores JDC; Pacheco-Fernández T; Hiriart M; Gutiérrez-Cirlos EB Cytokine; 2017 Nov; 99():214-224. PubMed ID: 28780379 [TBL] [Abstract][Full Text] [Related]
9. Donor liver apoptosis is associated with early allograft dysfunction and decreased short-term graft survival after liver transplantation. Zhu Z; Tang Y; Huang S; Zhao Q; Schroder PM; Zhang Z; Zhang Y; Sun C; Wang L; Ju W; Wang D; Guo Z; He X Clin Transplant; 2018 Dec; 32(12):e13438. PubMed ID: 30383902 [TBL] [Abstract][Full Text] [Related]
10. Early Allograft Dysfunction After Liver Transplantation Is Associated With Short- and Long-Term Kidney Function Impairment. Wadei HM; Lee DD; Croome KP; Mai ML; Golan E; Brotman R; Keaveny AP; Taner CB Am J Transplant; 2016 Mar; 16(3):850-9. PubMed ID: 26663518 [TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis. Barnes MA; McMullen MR; Roychowdhury S; Pisano SG; Liu X; Stavitsky AB; Bucala R; Nagy LE Hepatology; 2013 May; 57(5):1980-91. PubMed ID: 23174952 [TBL] [Abstract][Full Text] [Related]
12. The release of microRNA-122 during liver preservation is associated with early allograft dysfunction and graft survival after transplantation. Selten JW; Verhoeven CJ; Heedfeld V; Roest HP; de Jonge J; Pirenne J; van Pelt J; Ijzermans JNM; Monbaliu D; van der Laan LJW Liver Transpl; 2017 Jul; 23(7):946-956. PubMed ID: 28388830 [TBL] [Abstract][Full Text] [Related]
13. Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction. Bastos-Neves D; Salvalaggio PRO; Almeida MD Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):423-429. PubMed ID: 30853253 [TBL] [Abstract][Full Text] [Related]
14. Predictive model and risk factors associated with a revised definition of early allograft dysfunction in liver transplant recipients. Nicolau-Raducu R; Cohen AJ; Bokhari A; Bohorquez H; Bruce D; Carmody I; Bugeaud E; Seal J; Sonnier D; Nossaman B; Loss G Clin Transplant; 2017 Nov; 31(11):. PubMed ID: 28856732 [TBL] [Abstract][Full Text] [Related]
15. Relationship between ischemia/reperfusion injury and the stimulus of fibrogenesis in an experimental model: comparison among different preservation solutions. Camacho VR; de Fraga RS; Cerski CT; de Oliveira JR; Álvares-da-Silva MR Transplant Proc; 2011 Dec; 43(10):3634-7. PubMed ID: 22172818 [TBL] [Abstract][Full Text] [Related]
16. Comparison of macrophage migration inhibitory factor and neutrophil gelatinase-associated lipocalin-2 to predict acute kidney injury after liver transplantation: An observational pilot study. Baron-Stefaniak J; Schiefer J; Miller EJ; Berlakovich GA; Baron DM; Faybik P PLoS One; 2017; 12(8):e0183162. PubMed ID: 28813470 [TBL] [Abstract][Full Text] [Related]
17. Effect of dexmedetomidine on hepatic ischemia-reperfusion injury in the setting of adult living donor liver transplantation. Fayed NA; Sayed EI; Saleh SM; Ehsan NA; Elfert AY Clin Transplant; 2016 Apr; 30(4):470-82. PubMed ID: 26856320 [TBL] [Abstract][Full Text] [Related]
19. Urine macrophage migration inhibitory factor concentrations as a diagnostic tool in human renal allograft rejection. Brown FG; Nikolic-Paterson DJ; Chadban SJ; Dowling J; Jose M; Metz CN; Bucala R; Atkins RC Transplantation; 2001 Jun; 71(12):1777-83. PubMed ID: 11455258 [TBL] [Abstract][Full Text] [Related]
20. Association of genetic polymorphisms of macrophage inhibitory factor (MIF) and B-cell activating factor (BAFF) with the detection of donor specific antibodies in kidney allograft recipients. Chang Y; Shah T; Min DI Hum Immunol; 2017 Oct; 78(10):621-628. PubMed ID: 28624489 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]